NEWS & More

THE LATEST NEWS AND EVENTS

Jul 17, 2018

SomaLogic Licenses GNS Healthcare’s REFS™ technology for analysis of its SOMAscan®- derived proteomic data

Aug 20, 2017

Rare Disease Report Covers Alexion-GNS REFS Licensing Agreement

Aug 10, 2017

GNS Healthcare Licenses REFS™ Causal Machine Learning and Simulation Platform to Alexion to Accelerate Discovery of New Treatments for Rare Diseases